Trials / Completed
CompletedNCT02133053
Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal Spray
Non Interventional Study of Ectoin Allergy Nasal Spray Compared to Beclomethasone Nasal Spray
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Bitop AG · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin® Allergy Nasal Spray. In addition the effectiveness and safety shall be compared to a Beclomethasone nasal spray. The patient applies Ectoin® Rhinitis Nasal Spray or Beclomethasone nasal spray according to the instructions for use. The observation takes place over a period of 14 days. Response to treatment is recorded at day 7 and day 14 by the physician and in daily by the patient in a dairy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Medical Device, drug-like | Ectoin Allergy Nasal Spray |
| DRUG | Beclomethasone | Beclomethasone nasal spray |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2014-05-07
- Last updated
- 2014-05-07
Source: ClinicalTrials.gov record NCT02133053. Inclusion in this directory is not an endorsement.